Document is current
Any future updates will be listed below
-
Authors
Feng, Xuefei
Chen, Jinyan
Lian, Jianhong
Dong, Tianyue
Gao, Yingzhen
Zhang, Xiaojuan
Zhai, Yuanfang
Zou, Binbin
Guo, Yanlin
Xu, Enwei
Cui, Yongping
Zhang, Ling https://orcid.org/0000-0002-4100-0475
-
Funding
Funding for this research was provided by:
the National Natural Science Foundation of China (U21A20372, 81773150, 82303048)
the Science and Technology Innovation Team of Shanxi Province (202204051001024)
the Science and Technology Achievements Transformation Project of Shanxi Province (202204021301062)
Shanxi Scholarship Council of China (2021-082)
Shanxi Province Science Foundation for Youths (20210302124185, 202303021222128)
the National Key R&D Program of China (2021YFC2501001)
the Shenzhen Medical Research Fund (C2303002)
- License Information
-
More Information
Article History
Received: 12 June 2024
Revised: 13 November 2024
Accepted: 23 November 2024
First Online: 5 December 2024
Declarations
:
: The authors declare no competing interests with relevance to this study.
: The human cancer tissues used for IHC in our study were approved by the Ethics Committee on Human Research of Shanxi Medical University (Approval No. 2023pt11002, date: 2023.01.01). All animal experiments were performed according to protocols approved by the Institutional Animal Care and Use Committee of Shanxi Medical University (Approval No. 2021-324, date: 2021.10.13). The methods were consistent with the approved guidelines and were approved by the Ethics Committee of Shanxi Medical University. The study was carried out in accordance with the principles of the Basel Declaration and the Declaration of Helsinki.
: Not applicable.
